3

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: November 3, 2014
Period of Report: November 1, 2014
Accession Number: 0001144204-14-064726

View Document ↗ View on SEC.gov ↗